|
|
Song-Jung Kim, Atsuko Yatani, Dorothy E. Vatner, Satoshi Yamamoto, Yoshihiro Ishikawa, Thomas E. Wagner, Richard P. Shannon, Young-Kwon Kim, Gen Takagi, Kuniya Asai, Charles J. Homcy, Stephen F. Vatner
J Clin Invest. 1999;
103(7):1089
doi:10.1172/JCI4848
Abstract |
Full text
| PDF

W
e investigated the mechanisms responsible for altered contractile and relaxation function in overexpressed Gsα myocytes. Although baseline contractile function (percent contraction) in Gsα mice was similar to that of wild-type (WT) mice, left ventricular myocyte contraction, fura-2 Ca2+transients, and Ca2+ channel currents (ICa) were greater in Gsα mice in response to 10–8 M isoproterenol (ISO) compared with WT mice. The late phase of relaxation of the isolated myocytes and fura-2 Ca2+ transients was accelerated at baseline in Gsα but did not increase further with ISO. In vivo measurements using echocardiography also demonstrated enhanced relaxation at baseline in Gsα mice. Forskolin and CaCl2 increased contraction similarly in WT and Gsα mice. Rp-cAMP, an inhibitor of protein kinase, blocked the increases in contractile response and Ca2+ currents to ISO in WT and to forskolin in both WT and Gsα. It also blocked the accelerated relaxation in Gsα at baseline but not the contractile response to ISO in Gsα myocytes. Baseline measurements of cAMP and phospholambation phosphorylation were enhanced in Gsα compared with WT. These data indicate that overexpression of Gsα accelerates relaxation at end diastolic but does not affect baseline systolic function in isolated myocytes. However, the enhanced responses to sympathetic stimulation partly reflect increased Ca2+ channel activity; i.e the cellular mechanisms mediating these effects appear to involve a cAMP-independent as well as a cAMP-dependent pathway.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(5)
| Title and authors |
Publication |
Year |
Overexpression of Gsα compensates for myocyte loss in diabetic cardiomyopathyPresented in part at the American Heart Association meeting, New Orleans, Louisiana, November 2004.
Ashwani Malhotra, Barinder P.S. Kang, Himanshu Vashistha, Virender S. Yadav, Leonard G. Meggs
|
Can. J. Physiol. Pharmacol.
|
2008 |
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy
Shimako Yamamoto, Guiping Yang, Daniela Zablocki, Jing Liu, Chull Hong, Song-Jung Kim, Sandra Soler, Mari Odashima, Jill Thaisz, Ghassan Yehia, Carlos A. Molina, Atsuko Yatani, Dorothy E. Vatner, Stephen F. Vatner, Junichi Sadoshima
|
J. Clin. Invest.
|
2003 |
PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider
Matthew A Movsesian
|
Journal of Cardiac Failure
|
2003 |
Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy
Matthew A Movsesian, Rami Alharethi
|
Expert Opin. Investig. Drugs
|
2002 |
β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouse
Kuniya Asai, Gui-Ping Yang, Yong-Jian Geng, Gen Takagi, Sanford Bishop, Yoshihiro Ishikawa, Richard P. Shannon, Thomas E. Wagner, Dorothy E. Vatner, Charles J. Homcy, Stephen F. Vatner
|
J. Clin. Invest.
|
1999 |
|